In addition, this will be exceptionally useful in investigating the anti-tumor potential of anti-MUC16 mAb in the context of complex tumor microenvironments and strategizing combinations with checkpoint blockade molecules in pursuit of discovering novel immunotherapeutic regimens. This evidence concerns the gene MUC16 and neoplasm.